Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO

Jan 29 2026 10:10 AM IST
share
Share Via
Raaj Medisafe India Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 2 January 2026. While the rating change occurred earlier this month, the analysis and financial metrics discussed here reflect the company’s current position as of 29 January 2026, providing investors with the latest insights into its performance and outlook.
Raaj Medisafe India Ltd is Rated Hold by MarketsMOJO

Current Rating and Its Significance

The 'Hold' rating assigned to Raaj Medisafe India Ltd indicates a neutral stance for investors. It suggests that while the stock is not currently a strong buy, it also does not warrant a sell recommendation. Investors should consider maintaining their existing positions and monitor the company’s developments closely. This rating reflects a balance of strengths and challenges across key evaluation parameters including quality, valuation, financial trends, and technical indicators.

Quality Assessment

As of 29 January 2026, Raaj Medisafe India Ltd’s quality grade is assessed as average. The company operates in the packaging sector and is classified as a microcap, which often entails higher volatility and risk. One notable concern is the company’s high debt level, with an average debt-to-equity ratio of 3.93 times. This elevated leverage increases financial risk and could impact future profitability if not managed prudently. However, the company has demonstrated consistent operational performance, declaring positive results for the last three consecutive quarters, which supports the average quality rating.

Valuation Perspective

The valuation grade for Raaj Medisafe India Ltd is very attractive as of today. The stock trades at a discount relative to its peers’ historical valuations, with an enterprise value to capital employed ratio of just 2. This suggests that the market currently prices the company conservatively, potentially offering value to investors. The return on capital employed (ROCE) stands at 11.1%, which, while modest, supports the valuation attractiveness. Additionally, the company’s price-to-earnings-to-growth (PEG) ratio is an exceptionally low 0.1, indicating that earnings growth is not fully reflected in the stock price, a positive sign for value-oriented investors.

Financial Trend and Performance

The financial trend for Raaj Medisafe India Ltd is positive, reflecting strong growth momentum. As of 29 January 2026, the company’s net sales have grown at an impressive annual rate of 64.38%, while operating profit has increased by 60.53% annually. Profit after tax (PAT) for the nine months ended recently stands at ₹6.67 crores, marking a remarkable growth of 152.65%. Net sales for the same period reached ₹58.63 crores, underscoring robust top-line expansion. The company’s debtor turnover ratio is also noteworthy at 7.11 times, indicating efficient receivables management. Over the past year, the stock has delivered a total return of 30.20%, while profits have surged by 115.1%, highlighting strong operational leverage and growth potential.

Technical Analysis

From a technical standpoint, the stock is currently exhibiting a sideways trend. This suggests that while there is no clear directional momentum, the stock price is consolidating within a range. The one-month return of +29.64% and year-to-date gain of +19.95% indicate recent positive price action, but the six-month return of -13.41% reflects some volatility and correction in the medium term. Investors should watch for a breakout from this consolidation phase to signal a potential new trend.

Summary for Investors

In summary, Raaj Medisafe India Ltd’s 'Hold' rating reflects a balanced view of its current fundamentals and market position. The company’s strong financial growth and attractive valuation are tempered by its high debt levels and sideways technical trend. Investors should weigh these factors carefully, considering the stock as a potential candidate for holding rather than active buying or selling at this stage. Monitoring debt management and technical developments will be key to reassessing the stock’s outlook in the coming months.

Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!

  • - Hidden turnaround gem
  • - Solid fundamentals confirmed
  • - Large Cap opportunity

Discover This Hidden Gem →

Company Profile and Shareholding

Raaj Medisafe India Ltd operates within the packaging sector and is categorised as a microcap company. The majority shareholding is held by promoters, which often provides stability in corporate governance and strategic direction. However, the company’s high leverage remains a critical factor for investors to monitor, especially in the context of broader market conditions and sector dynamics.

Stock Performance Overview

As of 29 January 2026, the stock’s recent performance shows mixed trends. The one-day change is flat at 0.00%, while the one-week return is slightly negative at -1.21%. The one-month return is robust at +29.64%, reflecting recent positive momentum. Over three months, the stock has gained 6.64%, but the six-month return is negative at -13.41%, indicating some volatility. The year-to-date return stands at +19.95%, and the one-year return is a strong +30.20%, outperforming many peers in the packaging sector.

Implications for Investors

For investors, the 'Hold' rating suggests maintaining current positions while keeping a close watch on the company’s debt levels and market developments. The attractive valuation and strong financial growth provide a solid foundation, but the sideways technical trend and high leverage warrant caution. Investors seeking exposure to the packaging sector may consider Raaj Medisafe India Ltd as a stable holding with potential upside if debt management improves and technical momentum shifts positively.

Conclusion

Raaj Medisafe India Ltd’s current 'Hold' rating by MarketsMOJO, updated on 2 January 2026, reflects a nuanced view of the company’s strengths and risks. The latest data as of 29 January 2026 highlights strong growth and attractive valuation, balanced by financial leverage and technical consolidation. This rating serves as a guide for investors to adopt a measured approach, focusing on monitoring key financial and market indicators before making significant portfolio changes.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News